A cross-sectional National Institutes of Health (NIH)-supported study published in Menopauseshows that changes in cognitive function associated with menopause aren’t linear and, in fact, decline is most common in the first year after the final menstrual period.
A cross-sectional National Institutes of Health (NIH)-supported study published in Menopauseshows that changes in cognitive function associated with menopause aren’t linear and, in fact, decline is most common in the first year after the final menstrual period.
The aims of the Rochester Investigation of Cognition Across Menopause were to determine if cognitive function differs across stages of reproductive aging and to evaluate whether hormones or menopausal symptoms predict cognition in perimenopause. The 117 middle-aged women enrolled were categorized by reproductive stage based on criteria from the Stages of Reproductive Aging Workshop, with 34 in late reproduction, 28 in early menopause, 41 in late menopause, and 14 in early postmenopause. Most were well educated and more than 90% of participants were white, with mean age of 48.7 years.
Using a battery of neuropsychological tests, 6 domains of cognition were assessed, including verbal learning, verbal memory, and motor function. Menopausal symptoms and serum levels of estradiol and follicle-stimulating hormone (FSH) were also evaluated and the participants rated their symptoms of depression and anxiety, and their overall health, on questionnaires.
Multivariate regression of the impact of menopausal stage and symptoms on cognition showed that decreases in attention/working memory, verbal learning (P=0.02), verbal memory (P=0.02), and fine motor speed (P=0.03) were most evident in the first year after the final menstrual period. Higher levels of estradiol and FSH were associated only with fine motor speed (P=0.02 for both) but no associations were found between menopausal symptoms and cognitive scores.
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More